We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

39 hedge funds and large institutions have $7.14M invested in vTv Therapeutics in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

0.01% more ownership

Funds ownership: 0.2% → 0.21% (+0.01%)

0% more funds holding

Funds holding: 39 → 39 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

12% less capital invested

Capital invested by funds: $8.1M → $7.14M (-$965K)

Holders
39
Holders Change
–
Holders Change %
0%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
15
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$693K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$525K
3
Wells Fargo
Wells Fargo
California
+$187K
4
BlackRock
BlackRock
New York
+$97.1K
5
Two Sigma Investments
Two Sigma Investments
New York
+$87K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$347K
2
Renaissance Technologies
Renaissance Technologies
New York
-$299K
3
Squarepoint
Squarepoint
New York
-$58.7K
4
Goldman Sachs
Goldman Sachs
New York
-$43K
5
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$9K +$967 +11 +10%
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
$4.03K +$4.22K +48 +533%
Osaic Holdings
28
Osaic Holdings
Arizona
$4K – – –
Morgan Stanley
29
Morgan Stanley
New York
$3K -$4.22K -48 -55%
Legal & General Group
30
Legal & General Group
United Kingdom
$3K – – –
PA
31
Parallel Advisors
California
$3K – – –
Bank of America
32
Bank of America
North Carolina
$2K -$9.32K -106 -76%
AIP
33
Ameritas Investment Partners
Nebraska
$2K – – –
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$2K +$615 +7 +88%
Citigroup
35
Citigroup
New York
$1K -$1.49K -17 -57%
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$1K -$615 -7 -37%
PAM
37
Panagora Asset Management
Massachusetts
$1K +$1.14K +13 New
GWM
38
Geneos Wealth Management
Colorado
$1K +$2.2K +25 New
Millennium Management
39
Millennium Management
New York
$40 +$49.7K +566 New
VF
40
Virtu Financial
New York
– -$347K -3,860 Closed
Renaissance Technologies
41
Renaissance Technologies
New York
– -$299K -3,319 Closed
Goldman Sachs
42
Goldman Sachs
New York
– -$43K -477 Closed
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
– -$33K -363 Closed
SSB
44
Sandy Spring Bank
Maryland
– -$2K -19 Closed
1
2

VTVT Hedge Fund Activity: Q3 2020 in Review

39 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q3 2020, worth a combined $7.14M — down 12% from $8.1M a quarter earlier.

Fund positioning in VTVT was balanced in Q3 2020: 5 funds opened new positions, 5 closed out, 15 added to existing stakes and 11 trimmed.

The largest buyer was Two Sigma Advisers, adding an estimated $693K. The largest seller was Virtu Financial, exiting entirely with an estimated $347K sold.

  • 39 institutional investors held vTv Therapeutics (VTVT) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $7.14M of vTv Therapeutics stock for Q3 2020, down 12% quarter-over-quarter.
  • 5 funds opened new vTv Therapeutics positions in Q3 2020 and 5 closed out, a net change of 0 holders.
  • The largest vTv Therapeutics buyer in Q3 2020 was Two Sigma Advisers, an estimated $693K added.
  • The largest vTv Therapeutics seller in Q3 2020 was Virtu Financial, an estimated $347K sold.

Based on aggregated 13F filings for Q3 2020.